Ljungman, Per
Ljungman, Per, 1950-
Per Ljungman Swedish physician
VIAF ID: 54403994 ( Personal )
Permalink: http://viaf.org/viaf/54403994
Preferred Forms
- 200 _ | ‡a Ljungman ‡b Per
- 100 1 _ ‡a Ljungman, Per
- 100 1 _ ‡a Ljungman, Per
-
- 100 1 _ ‡a Ljungman, Per
-
-
-
- 100 1 _ ‡a Ljungman, Per
- 100 1 _ ‡a Ljungman, Per ‡d 1950-
-
- 100 0 _ ‡a Per Ljungman ‡c Swedish physician
4xx's: Alternate Name Forms (9)
5xx's: Related Names (3)
- 510 2 _ ‡a Karolinska Universitetssjukhuset ‡g Stockholm ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Karolinska institutet ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Stockholm ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
Cytostatika | |
Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus | |
Impact of ABO-mismatching following HLA-mismatched unrelated donor hematopoietic stem cell transplantation for AML: a report from the ALWP of the EBMT | |
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia | |
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation | |
Proceedings from the 5th International Cytomegalovirus Conference, May 21-24, 1995, Stockholm, Sweden | |
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol | |
Transplant infections |